Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/10/12 → 22/06/15 |
Long-term, prospective, multinational prallel-cohort study monitoring safety in patients with MS newly started with fingolimod once daily or treated with another approved disease-modifying therapy
- Butzkueven, Helmut (Primary Chief Investigator (PCI))
Project: Research